On ECHEMI

Jiangxi Synergy Pharmaceuticals Co., Ltd

Yichun,Jiangxi,China
Favorite Supplier
 1036 people visit

Company Profile

In 2004, Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in Fengxin County of Jiangxi Province. Our company is located in Fengxin Industrial Park of Jiangxi Province, 55 kilometers far from the downtown of Nanchang city, with the total area of 80,000 square meters, and construction area of 62,000 square meters; the new manufacture site (plant of second stage) with 240,000 square meters is under schedule to be built up. Factories of our company were constructed in accordance with the GMP standard, and the facilities were well-equipped according to international requirements for the production of APIs. Our main products are APIs and intermediates. The capacity and quality of our main products are in the leading level amongst all Chinese factories. We have about 500 sets of various glass-lined and metal reation kettles with the volumes from 50 to 20,000L and the total reaction volume of 3,000,000L. We are one of the most strict API manufacturers in China for quality management. Our main APIs all have their DMFs to support, Q7 and other ICH related documents are of good implementation. Passing official quality system inspection with zero-defect is our pursuit. Our main products have passed GMP audit by NMPA, US-FDA, PMDA, MFDS, etc. Meanwhile, we have received over 50 times of quality audits from our customers all over the world every year. Over 95% of our products are sold to more than 40 territories, and over 80% of them are sold in the markets of three regions of EU, USA and Japan, Korea. Our strong R&D potency is a guarantee to maintain market competitiveness, keep introducing new products, and receive processing orders. The annual R & D Input accounts for more than 6% of sales. Meanwhile, we pay more money to bring in talented personnel, extensively cooperate with scientific research institutions and R & D investment, all of which ensure the continuous improvements of R&D potency. Safety culture is an important part in Jiangxi Synergy's culture. We are in pursuit of the security management pattern of full participation and cooperative teams and implement of EHS management. Our security policy is Safety first, precaution crucial; Full-crew participation and comprehensive improvement; Practice the PDCA management pattern on base of risk management, create the safety environment of cooperative team and staff, and ensure the production safety. And people in Jiangxi Synergy believe that responsibility in EHS concept is an important guarantee for sustainable development of enterprise. We have formed our corporation culture with core philosophy of Seriousness, Honesty, Teamwork, Self-promotion in development. Seriousness is the most important working attitude we advocated, with which we are concentrating on implementing the first-rate management, training first-class talents, producing top-notch qualify, and establishing first-class enterprise. With the constant effort and support of our staff, our company is on the road of being one of the best-known APIs manufacture bases in China.

VIEW MORE VIEW LESS

Product List

Product Name Synonyms CAS No. Grate/Content Operate

1,1-Cyclohexanediacetic acid

1,1-Cyclohexanediacetic acid;NSC 169443;NSC 39839;1,1-Bis(carboxymethyl)cyclohexane;(1-Carboxymethyl-cyclohexyl)-acetic acid;2,2′-(Cyclohexane-1,1-diyl)diacetic acid;2-[1-(Carboxymethyl)cyclohexyl]acetic acid
4355-11-7 Inquiry

1-[2-Amino-1-(4-methoxyphenyl)-ethyl]-cyclohexanol hydrochloride

Cyclohexanol,1-[2-amino-1-(4-methoxyphenyl)ethyl]-,hydrochloride (1:1);Cyclohexanol,1-[2-amino-1-(4-methoxyphenyl)ethyl]-,hydrochloride,(±)-;Cyclohexanol,1-[2-amino-1-(4-methoxyphenyl)ethyl]-,hydrochloride;1-[2-Amino-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride;N,N-Didesmethylvenlafaxine hydrochloride;1-[2-Amino-1-(p-methoxyphenyl)ethyl]cyclohexanol hydrochloride
130198-05-9 Inquiry

1-[Cyano-(p-methoxyphenyl)methyl]cyclohexanol

Benzeneacetonitrile,α-(1-hydroxycyclohexyl)-4-methoxy-;Benzeneacetonitrile,α-(1-hydroxycyclohexyl)-4-methoxy-,(±)-;α-(1-Hydroxycyclohexyl)-4-methoxybenzeneacetonitrile;1-[Cyano(4-methoxyphenyl)methyl]cyclohexanol;α-(p-Methoxyphenyl)-α-(1-hydroxycyclohexyl)acetonitrile;1-[Cyano(p-methoxyphenyl)methyl]cyclohexanol;(4-Methoxyphenyl)-(1-hydroxycyclohex-1-yl)acetonitrile;2-(1-Hydroxycyclohexyl)-2-(4-methoxyphenyl)acetonitrile;131801-69-9;300827-97-8;606928-54-5
93413-76-4 Inquiry

1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester

1H-Benzimidazole-7-carboxylic acid,1-[[2′-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1′-biphenyl]-4-yl]methyl]-2-ethoxy-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester;Azilsartan medoxomil;TAK 491;(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-[[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate;Edarbi;(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate;Ipreziv
863031-21-4 Inquiry

2-Amino-3-(1,2-dihydro-2-oxoquinoline-4-yl)propanoic acid

Rebamipide Impurity 3;REBAMIPIDEINTERMEDIATE;2-Amino-3-(1,2-Dihydro-2-Oxoqu;1,2-dihydro-2-oxo-4-quinolinealanine;3-(2-OXO-1 2-DIHYDRO-4-QUINOLINYL)ALANI&;2-AMino-3-(1,2-dihydro-2-oxoquinoline-4-yl);2-Amino-3[2(1H)-Quinolinone-4-Yl],Rebamipide;2-Amino -3-[2(1H)-quinolinon-4-yl]-Propinonic;3-(2-Oxo-1,2-dihydro-4-quinolinyl)alanine;2-Amino-3[2(1H)-Quinolinone-4-Yl]-RopinonicAcidHcl
5162-90-3 Inquiry

2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole

2,5′-Bi-1H-benzimidazole,1,7′-dimethyl-2′-propyl-;1,7′-Dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole;2-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazole;4-Methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazole;1,7′-Dimethyl-2′-propyl-2,5′-bibenzimidazole;2-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole;1,7′-Dimethyl-2′-propyl-1H,1′H-2,5′-bibenzo[d]imidazole;2-n-Propyl-4-methyl-6-(1′-methylbenzimidazole-2-yl)benzimidazole
152628-02-9 Inquiry

2-[(4-Chloro-3-Methyl-2-Pyridinyl-methyl)thio]-1H-Benzimidazole

1H-Benzimidazole,2-[[(4-chloro-3-methyl-2-pyridinyl)methyl]thio]-;2-[[(4-Chloro-3-methyl-2-pyridinyl)methyl]thio]-1H-benzimidazole;2-[(4-Chloro-3-Methyl-2-pyridinyl)methylthio]-1H-benzimidazole;2-[[(4-Chloro-3-methyl-2-pyridyl)methyl]thio]-1H-benzimidazole;2-[(4-Chloro-3-methylpyridin-2-yl)methylsulfanyl]-1H-benzimidazole;2-(((4-Chloro-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole
103312-62-5 Inquiry

4-(2-Pyridinyl)benzaldehyde

Benzaldehyde,4-(2-pyridinyl)-;4-(2-Pyridinyl)benzaldehyde;4-(2-Pyridyl)benzaldehyde;2-(p-Formylphenyl)pyridine;4-Pyridin-2-ylbenzaldehyde;2-(4′-Formylphenyl)pyridine;2-(4-Formylphenyl)pyridine
127406-56-8 Inquiry

4-(METHYLAMINO)-3-NITROBENZOIC ACID

Benzoic acid,4-(methylamino)-3-nitro-;4-(Methylamino)-3-nitrobenzoic acid;NSC 138300;3-Nitro-4-methylaminobenzoic acid
41263-74-5 Inquiry

4-Bromomethyl-1,2-dihydroquinoline-2-one

4-Bromomethyl-2-quinolinol;4-(BROMOMETHYL)-2(1H)-QUINOLINONE;4-BROMOMETHYLQUINOLINONE;4-BROMOMETHYL-1,2-DIHYDROQUINOLIN-2-ONE;4-BROMOMETHYL-1,2-DIHYDROQUINOLINE-2-ONE;2(1H)-QUINOLINONE, 4-(BROMOMETHYL)-;4-Bromomethyl Carbostyril;4-(bromomethyl)-2-hydroxyquinoline
4876-10-2 Inquiry

4-Methoxybenzyl cyanide

Benzeneacetonitrile,4-methoxy-;Acetonitrile,(p-methoxyphenyl)-;4-Methoxybenzeneacetonitrile;p-Methoxybenzyl cyanide;(p-Methoxyphenyl)acetonitrile;p-Methoxybenzeneacetonitrile;(4-Methoxyphenyl)acetonitrile;p-Anisylacetonitrile;4-Methoxybenzyl cyanide;NSC 96;p-Methoxybenzylnitrile;2-(4-Methoxyphenyl)acetonitrile;PAI 106;1-(Cyanomethyl)-4-methoxybenzene
104-47-2 Inquiry

7-Methoxy-1-naphthylacetonitrile

1-Naphthaleneacetonitrile,7-methoxy-;7-Methoxy-1-naphthaleneacetonitrile;7-Methoxy-1-naphthylacetonitrile;1-Cyanomethyl-7-methoxynaphthalene;2-(7-Methoxy-1-naphthyl)acetonitrile;(7-Methoxynaphthalen-1-yl)acetonitrile;7-Methoxynaphthalene-1-acetonitrile;2-(7-Methoxynaphthalen-1-yl)acetonitrile
138113-08-3 Inquiry

Aceclofenac

Benzeneacetic acid,2-[(2,6-dichlorophenyl)amino]-,carboxymethyl ester;Aceclofenac;Falcol;Gerbin;2-[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetoxy]acetic acid;Airtal;Tresquim;Biofenac;PR 82/3;Aceclofar;Bristaflam;Glycolic acid 2-[o-(2,6-dichloroanilino)phenyl]acetate;Zerodol;Hifenac;Preservex;[2-[(2,6-Dichlorophenyl)amino]phenyl]acetoxyacetic acid;Hifenac-TL;Dolokind;Acepac;Flexidol;Aceclofenac BP;Aceclo;Aceclo Plus;[2-(2,6-Dichloro-phenylamino)-phenyl]-acetic acid carboxymethyl ester;2-[2-[2-(2,6-Dichloroanilino)phenyl]acetyl]oxyacetic acid
89796-99-6 Inquiry

AGOMELATINE

Acetamide,N-[2-(7-methoxy-1-naphthalenyl)ethyl]-;N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide;S 20098;N-[2-(7-Methoxy-1-naphthyl)ethyl]acetamide;Agomelatine;Valdoxan;N-[2-(7-Methoxynaphthalen-1-yl)ethyl]acetamide;AGO 178;Thymanax
138112-76-2 Inquiry

Atazanavir

2,5,6,10,13-Pentaazatetradecanedioic acid,3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-,1,14-dimethyl ester,(3S,8S,9S,12S)-;2,5,6,10,13-Pentaazatetradecanedioic acid,3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-,dimethyl ester,[3S-(3R*,8R*,9R*,12R*)]-;2,5,6,10,13-Pentaazatetradecanedioic acid,3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-,dimethyl ester,(3S,8S,9S,12S)-;1,14-Dimethyl (3S,8S,9S,12S)-3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioate;CGP 73547;BMS 232632;Atazanavir
198904-31-3 Inquiry

Candesartan

1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-;1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-;2-Ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid;CV 11974;Candesartan;Candesartan M1;2-Ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid;2-Ethoxy-1-[[2′-(1H-tetrazol-5-yl)-1,1′-biphenyl-4-yl]methyl]-7-benzimidazolecarboxylic acid;2-Ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid;3-[[2′-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl]-2-ethoxy-3H-benzimidazole-4-carboxylic acid;1-((2′-(1H-Tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid;2-Ethoxy-1-([4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl)-1H-1,3-benzodiazole-7-carboxylic acid;875515-04-1
139481-59-7 Inquiry

Candesartan cilexetil

1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-,1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester;1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-,1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester,(±)-;1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-,1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester;TCV 116;(±)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate,cyclohexyl carbonate (ester);Candesartan cilexetil;Atacand;TCY 116;Blopress;2-Ethoxy-1-[(2′-(1H-tetrazol-5-yl)-1,1′-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester;1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate;1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate;1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-([4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl)-1H-1,3-benzodiazole-7-carboxylate;139481-74-6;198077-85-9;2050948-41-7
145040-37-5 Inquiry

Celecoxib

Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-;4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide;Celecoxib;SC 58635;YM 177;Celebrex;Celocoxib;Celebra;Celecox;Xilebao;Medicoxib;Eurocox;Onsenal;4-[5-(p-Tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide;184007-95-2;194044-54-7
169590-42-5 Inquiry

Cilostazol

2(1H)-Quinolinone,6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-;6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone;Cilostazol;Cilostazole;Pletaal;OPC 21;OPC 13013;Pletal;6-[4-(1-Cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril;6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one;89332-50-3
73963-72-1 Inquiry

Dabigatran

β-Alanine,N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-;N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine;Dabigatran;BIBR 953;BIBR 953ZW
211914-51-1 Inquiry

CONTACT INFORMATION

Send an inquiry

Product Name:
Quantity:
Shipment Term:

China

  • China
  • Albania
  • Algeria
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina-faso
  • Burundi
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Cook Is.
  • Costa Rica
  • Croatia
  • Curacao
  • Cyprus
  • Czech
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hongkong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kampuchea (Cambodia )
  • Kazakstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao, China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Island
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Norfolk Island
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Cuinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion Island
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Martin
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Is
  • Somali
  • South Africa
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St.Lucia
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Taiwan, China
  • Tajikstan
  • Tanzania
  • Thailand
  • The British Virgin Islands
  • The Dominican Republic
  • The Islamic Republic of Mauritania
  • The Islands of st pierre and miquelon
  • The Turks and Caicos Islands
  • Timor-Leste
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Vietnam
  • Wallis et Futuna
  • Western Sahara
  • Yemen
  • Zaire
  • Zambia
  • Zimbabwe
  • Afghanistan
  • Belarus
  • Cuba
  • Iran
  • Iraq
  • Libya
  • North Korea
  • Sudan
  • Syria
  • Ukraine
  • Venezuela
Message:
0/2000
Accept quotations from other qualified suppliers on ECHEMI.com

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.